Abstract
Anal human papillomavirus (HPV) infection commonly affects men who have sex with men (MSM) and is associated with the development of anal cancer, with the highest prevalence in MSM who are positive for human immunodeficiency virus (HIV). The purpose of this study was to determine the prevalence of anal HPV infection and genotype distribution in Slovenian MSM and its correlation with behavioral patterns in order to predict the possible impact of quadrivalent HPV vaccine in this population. To our knowledge, this is the first study of prevalence and genotype distribution of anal HPV infection in MSM from any of the Eastern European countries. The study included 136 MSM who visited two outpatient offices from January 2007 through December 2008. All participants were clinically examined and tested for HIV, and anal swabs were taken for HPV testing. The results showed a high prevalence of anal HPV infection in both HIV-negative (75%) and HIV-positive (95%) MSM. Promiscuity and use of “poppers” (alkyl nitrites taken for recreational purposes through direct inhalation) were clearly associated with a higher prevalence of anal HPV infection. The four most common HPV genotypes were 6, 11, 16, and 18. The prevalence of anal HPV infection in Slovenian MSM is higher in comparison with other studies. Quadrivalent HPV vaccine could have great potential in this population.
[1] Melbye M., Sprogel P., Aetiological parallel between anal cancer and cervical cancer, Lancet, 1991, 338, 657–659 http://dx.doi.org/10.1016/0140-6736(91)91233-K10.1016/0140-6736(91)91233-KSearch in Google Scholar
[2] Palefsky J.M., Holly E.A., Gonzales J., Berline J., Ahn D.K., Greenspan J.S., Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer, Cancer Res, 1991, 51, 1014–1019 Search in Google Scholar
[3] zur Hausen H., Roots and perspectives of contemporary papillomavirus research, J Cancer Res Clin Oncol, 1996, 122, 3–13 http://dx.doi.org/10.1007/BF0120306710.1007/BF01203067Search in Google Scholar PubMed
[4] Baseman J.G., Koutsky L.A., The epidemiology of human papillomavirus infections, J Clin Virol, 2005, 32Suppl 1, S16–24 http://dx.doi.org/10.1016/j.jcv.2004.12.00810.1016/j.jcv.2004.12.008Search in Google Scholar PubMed
[5] Coleman N., Birley H.D., Renton A.M., Hanna N.F., Ryait B.K., Byrne M., et al., Immunological events in regressing genital warts, Am J Clin Pathol, 1994, 102, 768–774 10.1093/ajcp/102.6.768Search in Google Scholar PubMed
[6] Kodner C.M., Nasraty S., Management of genital warts, Am Fam Physician, 2004, 70, 2335–2342 Search in Google Scholar
[7] Lombard I., Vincent-Salomon A., Validire P., Zafrani B., de la Rochefordiere A., Clough K., et al., Human papillomavirus genotype as a major determinant of the course of cervical cancer, J Clin Oncol, 1998, 16, 2613–2619 10.1200/JCO.1998.16.8.2613Search in Google Scholar PubMed
[8] Fleischer A.B., Jr., Parrish C.A., Glenn R., Feldman S.R., Condylomata acuminata (genital warts): patient demographics and treating physicians, Sex Transm Dis, 2001, 28, 643–647 http://dx.doi.org/10.1097/00007435-200111000-0000610.1097/00007435-200111000-00006Search in Google Scholar PubMed
[9] Brown D.R., Schroeder J.M., Bryan J.T., Stoler M.H., Fife K.H., Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients, J Clin Microbiol, 1999, 37, 3316–3322 10.1128/JCM.37.10.3316-3322.1999Search in Google Scholar PubMed PubMed Central
[10] Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al., Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med, 2003, 348, 518–527 http://dx.doi.org/10.1056/NEJMoa02164110.1056/NEJMoa021641Search in Google Scholar PubMed
[11] Poljak M., Kocjan B., Fujs K., Humani virusi papilloma (HPV), Onkologija, 2005, 60–72 Search in Google Scholar
[12] Palefsky J.M., Holly E.A., Efirdc J.T., Da Costa M., Jay N., Berry J.M., et al., Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men, Aids, 2005, 19, 1407–1414 http://dx.doi.org/10.1097/01.aids.0000181012.62385.4a10.1097/01.aids.0000181012.62385.4aSearch in Google Scholar PubMed
[13] Chin-Hong P.V., Vittinghoff E., Cranston R.D., Buchbinder S., Cohen D., Colfax G., et al., Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study, J Infect Dis, 2004, 190, 2070–2076 http://dx.doi.org/10.1086/42590610.1086/425906Search in Google Scholar PubMed
[14] Palefsky J.M., Holly E.A., Ralston M.L., Jay N., Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIVnegative homosexual men, J Infect Dis, 1998, 177, 361–367 http://dx.doi.org/10.1086/51419410.1086/514194Search in Google Scholar
[15] Kreuter A., Brockmeyer N.H., Hochdorfer B., Weissenborn S.J., Stucker M., Swoboda J., et al., Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection, J Am Acad Dermatol, 2005, 52, 603–608 http://dx.doi.org/10.1016/j.jaad.2004.11.02610.1016/j.jaad.2004.11.026Search in Google Scholar
[16] Critchlow C.W., Hawes S.E., Kuypers J.M., Goldbaum G.M., Holmes K.K., Surawicz C.M., et al., Effect of HIV infection on the natural history of anal human papillomavirus infection, Aids, 1998, 12, 1177–1184 http://dx.doi.org/10.1097/00002030-199810000-0001010.1097/00002030-199810000-00010Search in Google Scholar
[17] de Pokomandy A., Rouleau D., Ghattas G., Vezina S., Cote P., Macleod J., et al., Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study, J Infect Dis, 2009, 199, 965–973 http://dx.doi.org/10.1086/59720710.1086/597207Search in Google Scholar
[18] Melbye M., Rabkin C., Frisch M., Biggar R.J., Changing patterns of anal cancer incidence in the United States, 1940–1989, Am J Epidemiol, 1994, 139, 772–780 10.1093/oxfordjournals.aje.a117073Search in Google Scholar
[19] Frisch M., Melbye M., Moller H., Trends in incidence of anal cancer in Denmark, Bmj, 1993, 306, 419–422 http://dx.doi.org/10.1136/bmj.306.6875.41910.1136/bmj.306.6875.419Search in Google Scholar
[20] Palefsky J.M., Human papillomavirus-related tumors, Aids, 2000, 14Suppl 3, S189–195 Search in Google Scholar
[21] Ryan D.P., Compton C.C., Mayer R.J., Carcinoma of the anal canal, N Engl J Med, 2000, 342, 792–800 http://dx.doi.org/10.1056/NEJM20000316342110710.1056/NEJM200003163421107Search in Google Scholar
[22] Qualters J.R., Lee N.C., Smith R.A., Aubert R.E., Breast and cervical cancer surveillance, United States, 1973–1987, MMWR CDC Surveill Summ, 1992, 41, 1–7 Search in Google Scholar
[23] Daling J.R., Weiss N.S., Hislop T.G., Maden C., Coates R.J., Sherman K.J., et al., Sexual practices, sexually transmitted diseases, and the incidence of anal cancer, N Engl J Med, 1987, 317, 973–977 http://dx.doi.org/10.1056/NEJM19871015317160110.1056/NEJM198710153171601Search in Google Scholar
[24] Goedert J.J., Cote T.R., Virgo P., Scoppa S.M., Kingma D.W., Gail M.H., et al., Spectrum of AIDS-associated malignant disorders, Lancet, 1998, 351, 1833–1839 http://dx.doi.org/10.1016/S0140-6736(97)09028-410.1016/S0140-6736(97)09028-4Search in Google Scholar
[25] Goedert J.J., The epidemiology of acquired immunodeficiency syndrome malignancies, Semin Oncol, 2000, 27, 390–401 Search in Google Scholar
[26] Frisch M., Biggar R.J., Goedert J.J., Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome, J Natl Cancer Inst, 2000, 92, 1500–1510 http://dx.doi.org/10.1093/jnci/92.18.150010.1093/jnci/92.18.1500Search in Google Scholar PubMed
[27] Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J., Cancer statistics, 2003, CA Cancer J Clin, 2003, 53, 5–26 http://dx.doi.org/10.3322/canjclin.53.1.510.3322/canjclin.53.1.5Search in Google Scholar PubMed
[28] Breese P.L., Judson F.N., Penley K.A., Douglas J.M., Jr., Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus, Sex Transm Dis, 1995, 22, 7–14 http://dx.doi.org/10.1097/00007435-199501000-0000210.1097/00007435-199501000-00002Search in Google Scholar PubMed
[29] van der Snoek E.M., Niesters H.G., Mulder P.G., van Doornum G.J., Osterhaus A.D., van der Meijden W.I., Human papillomavirus infection in men who have sex with men participating in a Dutch gaycohort study, Sex Transm Dis, 2003, 30, 639–644 http://dx.doi.org/10.1097/01.OLQ.0000079520.04451.5910.1097/01.OLQ.0000079520.04451.59Search in Google Scholar PubMed
[30] Simatherai D., Bradshaw C.S., Fairley C.K., Bush M., Heley S., Chen M.Y., What men who have sex with men think about the human papillomavirus vaccine, Sex Transm Infect, 2009, 85, 148–149 http://dx.doi.org/10.1136/sti.2008.03258110.1136/sti.2008.032581Search in Google Scholar PubMed
[31] Chin-Hong P.V., Vittinghoff E., Cranston R.D., Browne L., Buchbinder S., Colfax G., et al., Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study, J Natl Cancer Inst, 2005, 97, 896–905 http://dx.doi.org/10.1093/jnci/dji16310.1093/jnci/dji163Search in Google Scholar PubMed
[32] Wilson H., The poppers-HIV connection, Focus, 1999, 14, 5–6 Search in Google Scholar
© 2010 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
